JACC. Cardiovascular interventions
-
JACC Cardiovasc Interv · Jul 2012
Randomized Controlled TrialEverolimus-eluting stent implantation for unprotected left main coronary artery stenosis. The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) study.
This study sought to evaluate the safety and efficacy of second-generation drug-eluting stents (DES) for patients with unprotected left main coronary artery (ULMCA) stenosis. ⋯ Second-generation EES had a similar 18-month risk of MACCE for ULMCA stenosis as first-generation SES or CABG.